Biomed Pharmacother. 2023 May:161:114513.doi: 10.1016/j.biopha.2023.114513. Epub 2023 Mar 15. (IF:7.500).

中文速读

针对胶质母细胞瘤,使用U87和U251细胞及裸鼠皮下移植瘤模型,用Entranster-R4000转染Cx32 mRNA,研究GJB1-13k抑制肿瘤的作用机制。

小鼠瘤内mRNAU87U251

本文使用:小核酸转染试剂Entranster™-R4000

查看产品详情(含全部 223 篇文献) →

A new IRES-mediated truncated Cx32 isoform inhibits global mRNA translation to suppress glioblastoma

Affiliations

Affiliations

  • 1 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou (510080), Guangdong, China.
  • 2 Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou (510630), Guangdong, China.
  • 3 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou (510080), Guangdong, China. Electronic address: taol@mail.sysu.edu.cn.
  • 4 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou (510080), Guangdong, China. Electronic address: wangqin6@mail.sysu.edu.cn.

Free article

Abstract

Glioblastoma (GBM) is the most lethal malignant primary brain tumor. Although multimodal therapy has been applied for GBM, the median survival time remains less than 16 months. Thus, better therapeutic targets in GBM are urgently needed. Herein, we first identified five new N-terminal-truncated Cx32 isoforms (GJB1-28k, GJB1-22k, GJB1-20k, GJB1-15k, and GJB1-13k) and further demonstrated that they were generated via cap-independent internal translation through internal ribosome entry sites (IRESs) in the coding sequence of GJB1 mRNA. Among these isoforms, GJB1-13k inhibited proliferation, promoted apoptosis, and limited cell cycle progression in GBM cells by inhibiting global mRNA translation. In vivo experiments further confirmed the antitumor activity of GJB1-13k against GBM cells. In addition, TSR3, a ribosomal maturation factor, was demonstrated to directly interact with GJB1-13k. Moreover, GBM cells with high TSR3 expression exhibited low sensitivity to GJB1-13k treatment, while GJB1-13k sensitivity was restored by TSR3 knockdown. Our work identifies a new IRES-mediated protein, GJB1-13k, and suggests that overexpression of GJB1-13k in GBM cells with low TSR3 expression or combined targeting of GJB1-13k and TSR3 in GBM cells with high TSR3 expression constitutes a potential therapeutic strategy for GBM.

Keywords: GJB1; GJB1–13k; Glioblastoma; IRES; mRNA translation.

本文使用的产品

小核酸转染试剂Entranster™-R4000

已有 223 篇已发表文献

查看产品详情(含全部 223 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单